As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

emmm201302842.reviewer_comments.pdf517KReview Process File

Figure S1. RCAN1 is induced in human atherosclerotic arteries.

Figure S2. Rcan1 gene targeting ablates expression of Rcan1-1 and Rcan1-4.

Figure S3. HFD-induced body weight increase and lipid profile changes are not mediated by Rcan1.

Figure S4. Rcan1 gene targeting increases fibrous cap thickness.

Figure S5. Rcan1 gene targeting does not increase MMP2 or MMP9 expression.

Figure S6. Rcan1 gene targeting does not induce intraplaque haemorrhage.

Figure S7. SR-A expression is not affected by Rcan1 gene targeting.

Figure S8. Rcan1 is a modest regulator of cholesterol efflux in macrophages.

Figure S9. Rcan1 does not mediate macrophage chemotaxis.

Figure S10. Macrophage motility is inhibited by oxLDL in an Rcan1-dependent manner.

Figure S11. Rcan1 gene targeting increases IL10 gene expression in the aortic arch of atherosclerotic mice.

Figure S12. Rcan1 regulates Arg1 expression, antigen presentation and phagocytic activity in macrophages.

Figure S13. Rcan1 does not regulate iNos expression in atherosclerotic lesions.

Figure S14. Rcan1 does not alter the nature of BM reconstitution.

Figure S15. Metabolic parameters in transplanted mice.

Figure S16. Rcan1 gene targeting does not alter CN activity in macrophages.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.